172@29@17@140!~!172@29@0@53!~!|news|tags|moderna.html!~!news|moneycontrol|com!~!|controller|tag.php!~!is_mobile=false
you are here: HomeNewsModerna
moderna
Jump to
18 Results Found
  • Moderna would seek limited emergency use of COVID-19 vaccine based on early data Sep 17, 2020 05:51 PM IST

    Moderna would seek limited emergency use of COVID-19 vaccine based on early data

    Moderna's vaccine candidate - mRNA-1273 - is nearing the finish line in its push to enroll 30,000 individuals in a late-stage trial of a novel coronavirus va.

  • Rich countries have cornered 51% of future COVID-19 vaccine supply: Oxfam Sep 17, 2020 03:37 PM IST

    Rich countries have cornered 51% of future COVID-19 vaccine supply: Oxfam

    Supply deals have already been agreed for 5.303 billion doses, of which 2.728 billion (51 percent) have been bought by developed countries including the UK, US, Australia, Hong Kong & Macau, Japan, Switzerland and Israel, as well as the European Union

  • COVID-19 vaccine developers prepare joint safety pledge Sep 06, 2020 02:15 PM IST

    COVID-19 vaccine developers prepare joint safety pledge

    The companies would pledge to adhere to high scientific and ethical standards in the conduct of clinical studies and in their manufacturing processes, the Journal report said, citing the draft of a joint statement that is still being finalized.

  • Vaccine developer Moderna could slow COVID-19 trials to add at-risk minorities Sep 05, 2020 02:30 PM IST

    Vaccine developer Moderna could slow COVID-19 trials to add at-risk minorities

    The drug developer aims to recruit 30,000 healthy volunteers and said it expected enrollment in the late-stage study, which began in late-July, to be completed in September.

  • Coronavirus vaccine update: Moderna's candidate shows similar immune response in young and old volunteers Aug 26, 2020 11:00 PM IST

    Coronavirus vaccine update: Moderna's candidate shows similar immune response in young and old volunteers

    Significantly, the volunteers also produced higher levels of antibodies than those produced by patients who have recovered from COVID-19.

  • Moderna concludes advanced talks with EU for COVID-19 vaccine supply Aug 24, 2020 07:30 PM IST

    Moderna concludes advanced talks with EU for COVID-19 vaccine supply

    The potential agreement provides for an option for member states to buy an additional 80 million doses for a total of up to 160 million doses, the company said.

  • Moderna aims to price coronavirus vaccine at $50-$60 per course: Report Jul 29, 2020 09:54 AM IST

    Moderna aims to price coronavirus vaccine at $50-$60 per course: Report

    Moderna’s proposed price for the COVID-19 vaccine would apply to the United States and other high-income countries, according to a news report.

  • Moderna COVID-19 vaccine could be ready for use by end of year, says US Jul 27, 2020 10:15 PM IST

    Moderna COVID-19 vaccine could be ready for use by end of year, says US

    The trial is the first such late-stage study under the Trump administration's program to speed development of measures against the novel coronavirus, adding to hope that an effective vaccine will help end the pandemic.

  • Coronavirus vaccine update | Here are 3 most promising candidates in final stages of trial Jul 25, 2020 07:57 PM IST

    Coronavirus vaccine update | Here are 3 most promising candidates in final stages of trial

    With over 1.5 crore people across the globe having contracted the infection, the world is eagerly awaiting a vaccine that would bolster the global fight against COVID-19.

  • An infectious disease expert explains the results from Moderna's latest vaccine trials Jul 17, 2020 09:48 PM IST

    An infectious disease expert explains the results from Moderna's latest vaccine trials

    In the case of SARS-CoV-2, there is a spike protein, or the S-protein, which is the flag that the immune system needs to recognize as the signature of the virus.

  • EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines Jul 17, 2020 06:21 PM IST

    EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines

    The talks follow a deal reached in June by four EU states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations.

  • Moderna spars with US scientists over COVID-19 vaccine trials Jul 07, 2020 04:55 PM IST

    Moderna spars with US scientists over COVID-19 vaccine trials

    Some of the disagreements have stoked concerns over the young biotech firm's relative inexperience and what the sources described as its lack of staff and expertise to oversee the most critical phase of human trials.

  • WHO chief scientist says Astrazeneca, Moderna most advanced in COVID-19 vaccine race Jun 26, 2020 07:35 PM IST

    WHO chief scientist says Astrazeneca, Moderna most advanced in COVID-19 vaccine race

    Soumya Swaminathan said that Moderna's COVID-19 vaccine candidate was ‘not far behind’ Astrazeneca's, among more than 200 candidates, 15 of which have entered clinical trials

  • Moderna extends lipids deal to boost COVID-19 vaccine output May 28, 2020 02:07 PM IST

    Moderna extends lipids deal to boost COVID-19 vaccine output

    Moderna said last week that the vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, offering a glimmer of hope for a vaccine among the most advanced in development.

  • Explained | Moderna vaccine: Everything you need to know May 22, 2020 12:50 PM IST

    Explained | Moderna vaccine: Everything you need to know

    In this edition of the Moneycontrol's Explained series, find out if the vaccine is worth the hype.

  • First COVID-19 vaccine tested in the US shows promise in data from eight people May 18, 2020 10:27 PM IST

    First COVID-19 vaccine tested in the US shows promise in data from eight people

    Overall, the study showed the vaccine was safe and all study participants produced antibodies against the virus.

  • Moderna's COVID-19 vaccine shows promise in early study, shares soar May 18, 2020 07:04 PM IST

    Moderna's COVID-19 vaccine shows promise in early study, shares soar

    Eight patients who were administered Moderna's vaccine were found to have antibody levels similar to those in blood samples of people who have recovered from COVID-19, according to early results from the study conducted by the National Institutes of Health.

  • Moderna mulls upsizing largest biotech IPO since 2016: Report Dec 07, 2018 09:44 AM IST

    Moderna mulls upsizing largest biotech IPO since 2016: Report

    Moderna had originally planned to sell 21.7 million shares for between $22 and $24 per share.

Sections